Sale!

IDH1 Gene IDH1 Selective Sequencing of Exon 4 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The IDH1 gene, known for its role in cellular metabolism, has gained significant attention in medical research due to its mutation being implicated in various types of cancer, most notably gliomas, a type of brain tumor. The IDH1 Selective Sequencing of Exon 4 Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in exon 4 of the IDH1 gene, which is the most common site for alterations associated with oncogenesis. This precise genetic testing helps in the identification of specific mutations, providing critical information for the diagnosis, prognosis, and treatment planning for patients affected by or at risk of developing cancers associated with IDH1 mutations.

Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test employs cutting-edge sequencing technologies to accurately analyze the genetic material. With a focus on reliability and accuracy, DNA Labs UAE ensures that the results of the IDH1 Selective Sequencing of Exon 4 Genetic Test are delivered with the highest level of precision, aiding healthcare professionals in making informed decisions about patient care.

The cost of the IDH1 Selective Sequencing of Exon 4 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated nature of the test, including the use of advanced sequencing technologies and the expertise required to interpret the results. For patients and healthcare providers, the investment in this test can be invaluable for its potential to guide personalized treatment strategies and improve patient outcomes in the context of cancers associated with IDH1 mutations.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

IDH1 Gene IDH1 Selective Sequencing of Exon 4 Genetic Test

At DNA Labs UAE, we offer the IDH1 Gene IDH1 selective sequencing of exon 4 Genetic Test. This test is designed to analyze the IDH1 gene, also known as isocitrate dehydrogenase 1, which plays a crucial role in cellular metabolism.

Test Components

  • Price: 4400.0 AED

Sample Condition

The test can be performed using blood, extracted DNA, or one drop of blood on an FTA card.

Report Delivery

The test results will be delivered within 3 to 4 weeks.

Method

The IDH1 Gene IDH1 selective sequencing of exon 4 Genetic Test utilizes Next-Generation Sequencing (NGS) technology. This advanced sequencing method allows for the simultaneous sequencing of multiple DNA fragments, making it faster and more cost-effective than traditional sequencing methods.

Test Type

The IDH1 Gene IDH1 selective sequencing of exon 4 Genetic Test is specifically designed for the detection of cancer-related mutations.

Doctor

This test is recommended for oncologists who specialize in the diagnosis and treatment of cancer.

Test Department

The IDH1 Gene IDH1 selective sequencing of exon 4 Genetic Test is conducted in our Genetics department.

Pre Test Information

Prior to undergoing the IDH1 Gene IDH1 selective sequencing of exon 4 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by the IDH1 gene mutations.

Test Details

The IDH1 gene, also known as isocitrate dehydrogenase 1, is a gene that encodes an enzyme involved in cellular metabolism. Mutations in the IDH1 gene have been associated with various cancers, including gliomas, acute myeloid leukemia, and chondrosarcoma.

Selective sequencing of exon 4 refers to a specific method of genetic testing that focuses on sequencing only the fourth exon of the IDH1 gene. Exons are the coding regions of genes that contain the instructions for protein synthesis. By selectively sequencing exon 4, researchers can identify specific mutations or variations within this region of the IDH1 gene.

Next-generation sequencing (NGS) technology is utilized in this test. It is a high-throughput method used for sequencing DNA, allowing for the analysis of large amounts of genetic data in a short period of time. This technology has revolutionized genetic testing and research, enabling faster and more cost-effective analysis.

The selective sequencing of exon 4 using NGS technology allows for the identification of mutations or variations within the IDH1 gene. This information can be used for diagnostic purposes, prognostic assessments, or to guide personalized treatment options.

Test Name IDH1 Gene IDH1 selective sequencing of exon 4 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for IDH1 Gene IDH1, selective sequencing of exon 4 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IDH1 Gene IDH1, selective sequencing of exon 4 NGS Genetic DNA Test gene IDH1
Test Details

The IDH1 gene, also known as isocitrate dehydrogenase 1, is a gene that encodes an enzyme involved in cellular metabolism. Mutations in the IDH1 gene have been found to be associated with various cancers, including gliomas, acute myeloid leukemia, and chondrosarcoma.

Selective sequencing of exon 4 refers to a specific method of genetic testing that focuses on sequencing only the fourth exon of the IDH1 gene. Exons are the coding regions of genes that contain the instructions for protein synthesis. By selectively sequencing exon 4, researchers can identify specific mutations or variations within this region of the IDH1 gene.

Next-generation sequencing (NGS) is a high-throughput method used for sequencing DNA. It allows for the simultaneous sequencing of multiple DNA fragments, making it faster and more cost-effective than traditional sequencing methods. NGS technology has revolutionized genetic testing and research, enabling the analysis of large amounts of genetic data in a short period.

Therefore, selective sequencing of exon 4 using NGS technology allows for the identification of mutations or variations within the IDH1 gene that may be associated with certain diseases or conditions. This information can be used for diagnostic purposes, prognostic assessments, or to guide personalized treatment options.